Syncom Formulations (India) Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 745.73 million compared to INR 609.8 million a year ago. Revenue was INR 776.71 million compared to INR 677.49 million a year ago.

Net income was INR 74.05 million compared to INR 84.74 million a year ago. Basic earnings per share from continuing operations was INR 0.1 compared to INR 0.1 a year ago. Diluted earnings per share from continuing operations was INR 0.1 compared to INR 0.1 a year ago.

Basic earnings per share was INR 0.1 compared to INR 0.1 a year ago. Diluted earnings per share was INR 0.1 compared to INR 0.1 a year ago.